Orthopaedic 3D Surgical Planning Software Compared (2026): Ortoma, Materialise Mimics, 3D Slicer, Enhatch, and Browser-Based Alternatives

TL;DR

No single orthopaedic 3D planning platform wins on every axis. Ortoma leads on CE-marked arthroplasty planning, Materialise Mimics on validated engineering-grade segmentation, 3D Slicer on free research flexibility, and Enhatch on AI-native cloud automation. The newest category, browser-based client-side tools, trades cloud compute for zero-upload data governance. For surgeons, the right choice depends on three questions: is it CE-marked for your procedure, where does patient data go, and does it fit your existing DICOM workflow without a separate upload step.

Why Comparison Matters in 2026

Preoperative planning has moved from acetate templates to AI-assisted 3D reconstruction (see our 2026 planning guide). But the market is now crowded, and the platforms differ less in whether they do 3D planning than in how they handle segmentation accuracy, data governance, and clinical workflow.

Surgeons evaluating tools rarely get a like-for-like comparison. Vendor pages highlight strengths and omit trade-offs. This article compares the leading options on the axes that actually affect clinical use, with sources, and is explicit about what each does well and where it falls short.

The Comparison at a Glance

Regulatory status changes; verify current clearance for your jurisdiction and procedure before clinical use.

Platform by Platform

Ortoma

A CE-marked, cloud-based platform focused on total hip and knee arthroplasty. It generates a suggested plan, segmentation, landmarks, implant size and position, in minutes, which the surgeon validates and fine-tunes. Its strength is regulatory clearance plus clinical validation in arthroplasty. The trade-off is the server-side model: imaging is processed in the cloud, which creates data-processing obligations under KVKK, GDPR, and HIPAA. (Ortoma)

Materialise Mimics

The long-established reference for engineering-grade segmentation, widely used for patient-specific instrumentation and implant design. Segmentation is semi-automated and fully editable, which matters because automated output occasionally misses anatomy or includes artefacts. Mimics offers medical (regulated) variants. The trade-off is cost and workflow weight: it is a dedicated application, not an in-workflow step, and licensing is an institutional investment. A comparative study of 3D segmentation tools for hip planning places Mimics among the accuracy benchmarks.

3D Slicer

Free, open-source, and extraordinarily flexible, the workhorse of academic imaging research. With plugins (including deep-learning segmentation extensions) it can match much of what commercial tools do. The trade-offs: it is Research Use Only, the learning curve is steep, and there is no vendor accountability or clinical support. Ideal for building and validating pipelines, not for routine clinical throughput.

Enhatch

Positions itself as an AI-native cloud planning platform, automating segmentation and implant templating across joints. Cloud architecture enables heavy server-side processing without local hardware, the same trade-off as Ortoma applies: imaging is uploaded to external infrastructure.

Browser-Based Client-Side Tools

The newest category. The application loads in the surgeon's browser, DICOM parsing, multiplanar reconstruction, and AI inference run entirely on-device, and no patient data leaves the machine. This eliminates the data-governance complexity that server-side platforms carry. The honest trade-off is computational headroom: on-device inference cannot match a cloud GPU cluster for the heaviest full-volume tasks, so this approach favours targeted segmentation and measurement over massive batch reconstruction. The Salnus Surgeon Portal follows this architecture, using Cornerstone3D for GPU-accelerated reconstruction and ONNX Runtime Web for inference, with automated CT bone segmentation and alignment measurement.

The Three Questions That Actually Decide It

1. Is it CE-marked for your procedure?

A tool CE-marked for arthroplasty planning is not automatically cleared for osteotomy or trauma. Regulatory status is procedure-specific. Research Use Only tools (3D Slicer, most browser tools today) are valuable for evaluation and research but should not drive clinical decisions without appropriate validation.

2. Where does patient data go?

Server-side platforms (Ortoma, Enhatch) upload imaging to the cloud, powerful, but creating data-processing obligations. Local installs (Mimics, Slicer) keep data on-premises at the cost of hardware and IT. Client-side browser tools keep data on the device entirely. For independent surgeons and clinics without a dedicated IT/governance team, this difference is often decisive.

3. Does it fit your DICOM workflow?

A DICOM-native tool reads pixel spacing and slice thickness automatically, so measurements are physically calibrated, not pixel-estimated. A tool that requires a separate upload-and-wait step adds friction that, in practice, determines whether a tool gets used after the first month.

Where AI Helps, and Where It Doesn't

Across all these platforms, the evidence is consistent: AI reliably accelerates bone segmentation and geometric measurement, reducing hours of manual work to minutes and lowering inter-observer variability. What AI does not do is replace surgical judgment, and surveys reflect this: roughly 91% of orthopaedic surgeons expect AI to act as a complementary tool rather than a replacement (Frontiers, 2025). Platforms that present themselves as autonomous decision-makers, rather than as the surgeon's second pair of eyes, should be approached with caution.

FAQ

Which orthopaedic 3D planning software is most accurate? For segmentation accuracy, engineering-grade tools (Materialise Mimics) and validated cloud platforms (Ortoma for arthroplasty) set the benchmark. Accuracy is task-specific: a tool validated for hip segmentation is not automatically accurate for knee osteotomy planning.

What is the best free orthopaedic segmentation software? 3D Slicer is the leading free, open-source option, powerful and extensible, but Research Use Only and requiring technical setup.

Do I have to upload patient scans to the cloud? Not necessarily. Server-side platforms require upload; browser-based client-side tools process imaging on your device with no upload, which simplifies KVKK/GDPR/HIPAA obligations.

Can AI replace the surgeon in planning? No. Current evidence and surgeon consensus treat AI as augmentation. It automates measurement and segmentation; the surgical strategy remains the surgeon's.

The Takeaway

There is no universal best. Match the tool to the procedure (regulatory fit), your data-governance capacity (where data lives), and your workflow (DICOM-native, low-friction). For arthroplasty with institutional support, CE-marked cloud platforms lead. For privacy-first independent practice without IT overhead, client-side browser tools are the emerging alternative.

Explore the Salnus Surgeon Portal →

---

Disclaimer: This article is for educational and research purposes only. Salnus tools are designated for Research Use Only (RUO) and are not cleared medical devices. Mention of third-party products is for educational context only and does not imply endorsement or comparison of clinical equivalence. Clinical decisions should be made by qualified physicians, and regulatory status should be independently verified for your jurisdiction.

References:

• Comparison of Three 3D Segmentation Software Tools for Hip Surgical Planning. PMC, 2022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323631/
• AI and multimodal imaging in orthopaedics: from technological advances to clinical translation. Frontiers in Medicine, 2025. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1728248/full
• Reliable prediction of implant size and axial alignment in AI-based 3D preoperative planning for TKA. PMC, 2024. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11266554/
• Salnus Research Group. 3D-Printed Patient-Specific Guides for Knee Reconstruction. OJSM, 2026.